Cargando…
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Chemoprophylaxis is currently the best available prevention from malaria, but its efficacy is compromised by non-adherence to medication. Here we develop a long-acting injectable formulation of atovaquone solid drug nanoparticles that confers long-lived prophylaxis against Plasmodium berghei ANKA ma...
Autores principales: | Bakshi, Rahul P., Tatham, Lee M., Savage, Alison C., Tripathi, Abhai K., Mlambo, Godfree, Ippolito, Matthew M., Nenortas, Elizabeth, Rannard, Steve P., Owen, Andrew, Shapiro, Theresa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778127/ https://www.ncbi.nlm.nih.gov/pubmed/29358624 http://dx.doi.org/10.1038/s41467-017-02603-z |
Ejemplares similares
-
Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito
por: Balta, Victoria A., et al.
Publicado: (2023) -
Transmissibility of clinically relevant atovaquone-resistant Plasmodium falciparum by anopheline mosquitoes
por: Balta, Victoria A., et al.
Publicado: (2023) -
Ex vivo transdermal delivery of (3)H-labelled atovaquone solid drug nanoparticles: a comparison of topical, intradermal injection and microneedle assisted administration
por: Morris, Sam, et al.
Publicado: (2023) -
Immune Regulation of Plasmodium Is Anopheles Species Specific and Infection Intensity Dependent
por: Simões, Maria L., et al.
Publicado: (2017) -
Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?
por: Tatham, Lee M., et al.
Publicado: (2019)